Saturday 17 October 2026 Export PTPI’s income statement to Excel — free account

Petros Pharmaceuticals, Inc.

PTPI Healthcare Drug Manufacturers Specialty & Generic

In the quarter to June 2026, revenue grew 1,070.6%, EPS grew 76.7% and free cash flow grew 71.3%, each against the same quarter a year earlier.

0.00 0.00 NaN

Follow PTPI

Alert me

Market cap: $1.0M
P/E: 0.0×
Fwd P/E: −0.3×
Dividend yield: —
F-score: 4/9
Altman Z: −16.96
Beneish M: −3.26
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(1,475.74%)	1,900.89%	1,085.80%	(710.28%)
ROA Full definition →		(356.67%)	(553.07%)	(385.60%)	(334.15%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(1,420.44%)	(1,521.79%)	(2,394.50%)	(2,608.36%)
Average Days of Receivables Full definition →		—	—	—	—
Free Cash Flow per Share Full definition →		(0.11)	(0.24)	(0.13)	(0.08)
Free Cash Flow Full definition →		(4.84)	(6.73)	(5.86)	(3.72)
Other line items
Cash ROIC Full definition →		(51.24%)	(84.10%)	(95.67%)	(88.69%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	—	0.00%	0.00%
Operating CF/Net income Full definition →		0.10	0.15	0.14	0.20
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(0.11)	(0.24)	(0.13)	(0.08)
Capex per Share Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates